Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells-Reference-Cited by-同舟云学术

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

Published:2005-10-16 Issue:11 Volume:11 Page:1238-1243
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Zhang Hua,Chua Kevin S,Guimond Martin,Kapoor Veena,Brown Margaret V,Fleisher Thomas A,Long Lauren M.,Bernstein Donna,Hill Brenna J,Douek Daniel C,Berzofsky Jay A,Carter Charles S,Read E J,Helman Lee J,Mackall Crystal L

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1312.pdf

Reference31 articles.

1. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21 (2001).

2. Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73 (2001).

3. Shevach, E.M. Regulatory T cells in autoimmmunity*. Annu. Rev. Immunol. 18, 423–449 (2000).

4. Sakaguchi, S. et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18–32 (2001).

5. Malek, T.R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167–178 (2002).

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating regulatory T cell migration in the treatment of autoimmunity and autoinflammation;Current Opinion in Pharmacology;2024-08

2. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies;Experimental Hematology & Oncology;2024-02-23

3. Low-dose IL-2 therapy in autoimmune diseases: An update review;International Reviews of Immunology;2023-10-26

4. Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation;Critical Reviews in Oncology/Hematology;2023-05

5. Neoantigens: promising targets for cancer therapy;Signal Transduction and Targeted Therapy;2023-01-06